Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iodotyrosine deiodinase 1 (IYD) is an FMN-dependent enzyme present on the apical membrane of thyroid follicular cells and is essential for iodide salvage during thyroid hormone biosynthesis. IYD catalyzes reductive deiodination of mono- and diiodotyrosine, byproducts of thyroglobulin hydrolysis, releasing iodide for reutilization in new hormone synthesis. This process helps maintain both iodide and thyroid hormone levels, supporting metabolic rate, protein expression, and temperature regulation. IYD is a membrane-bound flavoprotein belonging to the nitroreductase superfamily and forms a functional dimer with active site lid domains that sequester and stabilize substrate interactions. Genetic deficiency or mutations in IYD lead to loss of enzyme activity, ineffective iodide salvage, and various thyroid-related diseases including hypothyroidism and developmental impairment. Diagnosis of its deficiency is possible by measuring elevated levels of iodotyrosine derivatives in blood and urine, making it useful as a biomarker for congenital hypothyroidism. There are currently no approved drugs specifically targeting IYD, but its unique structure and catalytic mechanism make it a promising candidate for biotechnological or therapeutic development.
Reductive deiodination: catalyzes removal of iodine from mono- and diiodotyrosine using NADPH and FMN as a cofactor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iodotyrosine deiodinase 1 (IYD).